Cargando…
New perspectives on molecular targeted therapy in ovarian clear cell carcinoma
Ovarian clear cell carcinomas (OCCCs) account for about 5–13% of all epithelial ovarian carcinomas in Western populations. It is characterised by resistance to conventional platinum-based chemotherapy, and new therapeutic strategies are urgently required. This article will focus on how recent discov...
Autores principales: | Tan, D S P, Miller, R E, Kaye, S B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3668466/ https://www.ncbi.nlm.nih.gov/pubmed/23558892 http://dx.doi.org/10.1038/bjc.2013.126 |
Ejemplares similares
-
Targeted anti-vascular therapies for ovarian cancer: current evidence
por: Hall, M, et al.
Publicado: (2013) -
Immunotherapy: A new standard in the treatment of metastatic clear cell renal cell carcinoma
por: Popovic, Maja, et al.
Publicado: (2022) -
Molecular therapy for the treatment of hepatocellular carcinoma
por: Greten, T F, et al.
Publicado: (2009) -
Functional imaging: what evidence is there for its utility in clinical trials of targeted therapies?
por: Tunariu, N, et al.
Publicado: (2012) -
Tracing and targeting cancer stem cells: New venture for personalized molecular cancer therapy
por: Radpour, Ramin
Publicado: (2017)